A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens(KU Leuven), Д. А. Шапиро(University of Padua), Velimir A. Luketic(University of Padua), Leigh MacConell(Intercept Pharmaceuticals (United States)), Ulrich Beuers(Amsterdam University Medical Centers), Hemant Shah(University Health Network), Simon Hohenester(LMU Klinikum), G. Mazzella(University of Bologna), Gideon M. Hirschfield(University of Birmingham), Christopher L. Bowlus(University of Padua), Bettina E. Hansen(University of Padua), Jarosław Reguła(The Maria Sklodowska-Curie National Research Institute of Oncology), Shawn Sheeron(University of Padua), Richard Pencek(University of Padua), Tonya Marmon(University of Padua), Karel J. van Erpecum(University of Padua), Roya Hooshmand-Rad(University of Padua), Annarosa Floreani(University of Padua), Paul J. Pockros(Scripps Clinic), Mark Pruzanski(University of Padua), Pietro Invernizzi(University of Milano-Bicocca), Keith D. Lindor(University of Padua), Joost P.H. Drenth(Radboud University Nijmegen), Vı́ctor Vargas(Universitat Autònoma de Barcelona), Pietro Andreoné, Hanns–Ulrich Marschall(University of Padua), Michael Trauner(Medical University of Graz), Simone I. Strasser(University of Padua), Kris V. Kowdley(Washington State University Spokane), Catherine Vincent(University of Padua), David Jones(University of Padua), Mitchell L. Shiffman(Bon Secours Health System)
New England Journal of Medicine
August 17, 2016
Cited by 1,101


Related Papers